Adnan Said | Medicine | Best Researcher Award

Best Researcher Award

Adnan Said
University of Wisconsin School of Medicine and Public Health

Adnan Said
Affiliation University of Wisconsin School of Medicine and Public Health
Country United States
Scopus Id 35582909600
Documents 107
Citation 5,510
h-index 35
Subject Area Medicine
Event International Popular Scientist Awards
Orcid 0000-0001-9944-4071

Adnan Said is a medicine researcher affiliated with the University of Wisconsin School of Medicine and Public Health in the United States. The researcher profile supplied for this article lists 107 documents, 5,510 citations, and an h-index of 35 in Scopus, with research activity represented across hepatology, interventional radiology, liver transplantation, portal hypertension, and related clinical and translational areas. The publication record includes collaborative studies addressing transjugular intrahepatic portosystemic shunt (TIPS) procedures, gastrointestinal bleeding, liver fibrosis, and transplantation. [1]

Abstract

This academic recognition profile presents the research record of Adnan Said, whose supplied Scopus profile contains 107 documents, 5,510 citations, and an h-index of 35. His publication contributions represented in the supplied record focus substantially on liver-related clinical research, including portal hypertension, TIPS, gastrointestinal bleeding, liver transplantation, hepatic fibrosis, and associated diagnostic and therapeutic questions. The listed publications also demonstrate collaboration across multidisciplinary research groups involving hepatology, interventional radiology, transplantation, nuclear medicine, and related clinical sciences. [1]

Keywords

Adnan Said; Medicine; Hepatology; Liver Disease; Portal Hypertension; TIPS; Liver Transplantation; Gastrointestinal Bleeding; Liver Fibrosis; Interventional Radiology; Clinical Research; Translational Medicine; Research Impact.

Introduction

Research in hepatology and liver medicine encompasses complex interactions between chronic liver disease, portal hypertension, transplantation, vascular interventions, and complications such as gastrointestinal bleeding. Contemporary clinical investigation in these areas frequently combines patient outcomes, procedural variables, diagnostic imaging, and translational approaches. The publications supplied for this profile place Adnan Said within this multidisciplinary research environment, with several studies examining outcomes associated with TIPS and liver transplantation. [2]

Research Profile

The supplied bibliometric information identifies Adnan Said as a medicine researcher with a Scopus author identifier of 35582909600. The stated profile includes 107 documents, 5,510 citations, and an h-index of 35. These indicators describe the publication and citation record supplied for this recognition page and should be interpreted in the context of the coverage, indexing practices, author-disambiguation procedures, and update timing of the relevant database. [1]

The supplied publications demonstrate substantial collaborative authorship. The listed studies involve investigators from different clinical and research specialties and include multi-author ALTA Group investigations. Such collaboration is particularly relevant to complex liver-care research, where procedural outcomes, patient characteristics, imaging, transplantation, and clinical management may require integrated expertise.

Research Contributions

The supplied publications identify several recurring research themes. One area concerns outcomes following TIPS, a procedure used in the management of selected complications of portal hypertension. A 2025 ALTA Group study examined portal hypertensive gastropathy and MELD-Na score in relation to recurrent gastrointestinal bleeding after TIPS. [1]

Another contribution concerns changes in platelet count following TIPS creation. The 2023 study was conducted by the ALTA Group and investigated platelet-count changes after the procedure, contributing to the broader evaluation of physiological and clinical outcomes associated with TIPS. [2]

Publications

The following publications are drawn from the supplied Crossref-indexed publication information and represent selected research contributions associated with Adnan Said.

  1. Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics.
  2. Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. Journal of Vascular and Interventional Radiology.
  3. The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology.
  4. Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model. Journal of Nuclear Medicine.
  5. Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report. Transplant Infectious Disease.

Research Impact

The supplied Scopus metrics of 5,510 citations and an h-index of 35 provide bibliometric measures of the visibility and citation history associated with the identified author profile. [1] Bibliometric indicators are quantitative measures and do not independently establish the clinical effectiveness, methodological quality, or practical significance of individual studies.

Within the supplied publication sample, the research addresses clinically relevant questions concerning TIPS, portal hypertension, gastrointestinal bleeding, hemodynamic factors, liver fibrosis imaging, and transplantation. The combination of clinical studies, collaborative group research, and translational investigation indicates engagement with multiple dimensions of liver medicine. [1] [2] [3] [4] [5]

Award Suitability

For the purposes of the International Popular Scientist Awards, the supplied record provides several documented elements relevant to an academic recognition profile: a substantial indexed publication record, reported citation activity, an h-index of 35, and research contributions in medicine. The selected publications demonstrate work in liver-related clinical and translational research, including TIPS outcomes, portal hypertension, liver fibrosis imaging, and transplantation. [1]–[5]

Conclusion

Adnan Said’s supplied academic profile represents a research portfolio in medicine with notable emphasis on hepatology, liver-related interventions, transplantation, portal hypertension, and translational imaging. The stated Scopus record comprises 107 documents, 5,510 citations, and an h-index of 35. The selected publications further document participation in collaborative investigations addressing TIPS outcomes, gastrointestinal bleeding, platelet changes, hemodynamics, liver fibrosis, and transplantation. [1]–[5]

References

  1. Hu, K.; Sedki, M.; Kwong, A.; Kesselman, A.; Kolli, K. P.; Morelli, G.; Spengler, E.; Said, A.; Lai, J.; Desai, A.; et al. (2025). Portal Hypertensive Gastropathy and MELD-Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study. Alimentary Pharmacology & Therapeutics.
    https://doi.org/10.1111/apt.18362
  2. Wong, R. J.; Ge, J.; Boike, J.; German, M.; Morelli, G.; Spengler, E.; Said, A.; Desai, A.; Couri, T.; Paul, S.; et al. (2023). Change in Platelet Count after Transjugular Intrahepatic Portosystemic Shunt Creation: An Advancing Liver Therapeutic Approaches (ALTA) Group Study. Journal of Vascular and Interventional Radiology.
    https://doi.org/10.1016/j.jvir.2023.04.015
  3. Bommena, S.; Mahmud, N.; Boike, J. R.; Thornburg, B. G.; Kolli, K. P.; Lai, J. C.; German, M.; Morelli, G.; Spengler, E.; Said, A.; et al. (2023). The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study. Hepatology.
    https://doi.org/10.1097/HEP.0000000000000283
  4. Pirasteh, A.; Periyasamy, S.; Meudt, J. J.; Lui, Y.; Lee, L. M.; Schachtschneider, K. M.; Schook, L. B.; Gaba, R. C.; Mao, L.; Said, A.; et al. (2022). Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor Positron Emission Tomography in a Human-sized Swine Model. Journal of Nuclear Medicine.
    https://doi.org/10.2967/jnumed.121.263736
  5. Said, A.; Weiss, M.; Varhelyi, A.; Farago, R.; Ballweg, C.; Rice, J.; Agarwal, P.; Fernandez, L.; Foley, D. (2021). Utilization of hepatitis C viremic donors for liver transplant recipients without hepatitis C. A veterans transplant center report. Transplant Infectious Disease.
    https://doi.org/10.1111/tid.13466
  6. Elsevier. (n.d.). Scopus author details: Adnan Said, Author ID 35582909600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35582909600

Hayam AlRasheed | Telepharmacy | Innovative Research Award

Innovative Research Award

Hayam AlRasheed

Princess Nourah University, Saudi Arabia

Hayam AlRasheed
Affiliation Princess Nourah University
Country Saudi Arabia
Scopus ID 58411797200
Documents 49
Citations 224
h-index 8
Subject Area Telepharmacy
Event International Popular Scientist Awards
ORCID 0009-0002-6186-848X

Hayam AlRasheed the Innovative Research Award recognizes scholarly contributions that demonstrate sustained academic engagement, measurable research visibility, and emerging influence in interdisciplinary healthcare studies. Hayam AlRasheed of Princess Nourah University has contributed to the field of telepharmacy through research activities that support healthcare accessibility, patient communication systems, and digital pharmaceutical services within modern healthcare environments.[1] The recognition is associated with the International Popular Scientist Awards, which acknowledge researchers contributing to evidence-based innovation and academic advancement.[4]

Abstract

This academic recognition article documents the scholarly profile and research activities of Hayam AlRasheed, a researcher affiliated with Princess Nourah University in Saudi Arabia. The article highlights research productivity indexed through Scopus metrics, interdisciplinary engagement in telepharmacy-related healthcare innovation, and contributions toward pharmaceutical communication and digital healthcare accessibility.[1] The recognition aligns with the objectives of the International Popular Scientist Awards, which emphasize scientific visibility, academic integrity, and evidence-driven research contributions in emerging fields of healthcare services.[4]

Keywords

Telepharmacy, Digital Healthcare, Pharmaceutical Services, Healthcare Communication, Clinical Pharmacy, Research Visibility, Scopus Indexing, Healthcare Innovation, Academic Recognition, Saudi Arabia.

Introduction

Telepharmacy has emerged as an important component of modern healthcare systems, particularly in improving pharmaceutical access, patient consultation mechanisms, and remote healthcare support services.[2] Researchers working in this domain contribute to the integration of communication technologies with pharmacy practice to improve patient outcomes and healthcare delivery models.[3]

Hayam AlRasheed has participated in scholarly activities associated with telepharmacy and healthcare innovation while contributing to academic research visibility through indexed publications and interdisciplinary collaboration. Her work reflects the broader transition toward digital healthcare ecosystems that support efficient pharmaceutical practices and evidence-based healthcare communication strategies.[1]

Research Profile

The research profile of Hayam AlRasheed demonstrates scholarly engagement within healthcare-related research environments, particularly in telepharmacy and pharmaceutical communication studies. Indexed academic metrics indicate publication activity, citation performance, and sustained participation in peer-reviewed scientific literature.[1]

Research Contributions

Research contributions associated with telepharmacy often involve improving patient-centered pharmaceutical services, remote consultation systems, medication accessibility, and healthcare communication practices.[2] Scholarly work in this domain supports healthcare modernization through digital integration and evidence-based healthcare delivery approaches.[3]

Hayam AlRasheed’s academic profile reflects engagement with healthcare innovation themes relevant to pharmaceutical service optimization and interdisciplinary healthcare studies. Such research contributes to ongoing discussions regarding digital healthcare transformation and pharmaceutical accessibility within clinical and community healthcare systems.[5]

Publications

The publication record indexed within international academic databases reflects continued scholarly activity and participation in peer-reviewed scientific communication. Indexed publications contribute to research visibility and facilitate academic collaboration across healthcare and pharmaceutical sciences.[1]

Research Impact

Research impact is commonly evaluated through citation indicators, publication indexing, scholarly engagement, and interdisciplinary applicability. The available Scopus metrics associated with Hayam AlRasheed indicate measurable academic visibility within healthcare-related scientific literature.[1]

The evolving role of telepharmacy in healthcare systems highlights the importance of research addressing healthcare accessibility, remote pharmaceutical consultation, and digital patient support. Contributions in these areas may support healthcare institutions, policy discussions, and future research initiatives focused on digital healthcare transformation.[2]

Award Suitability

The Innovative Research Award emphasizes scholarly excellence, research visibility, interdisciplinary relevance, and measurable contribution to scientific advancement. Hayam AlRasheed’s academic profile demonstrates alignment with these criteria through publication activity, healthcare-related research engagement, and indexed scholarly impact.[1]

Participation in telepharmacy research and healthcare innovation initiatives further supports the suitability of this recognition within the context of contemporary healthcare transformation and evidence-based digital healthcare services.[3]

Conclusion

The academic profile of Hayam AlRasheed reflects sustained scholarly engagement in telepharmacy and healthcare innovation research. Through indexed publications, interdisciplinary participation, and measurable citation metrics, the researcher contributes to ongoing developments in digital healthcare and pharmaceutical communication systems.[1] The Innovative Research Award within the International Popular Scientist Awards framework recognizes these contributions as part of broader efforts to encourage evidence-based scientific advancement and healthcare innovation.[4]

References

  1. Elsevier. (n.d.). Scopus author details: Hayam AlRasheed, Author ID 58411797200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=58411797200
  2. Alexander, E., Butler, C. D., Darr, A., Jenkins, M. T., Long, R. D., Shipman, C. J., & Stratton, T. P. (2017). ASHP statement on telepharmacy. American Journal of Health-System Pharmacy, 74(9), e236-e241.
    DOI: https://doi.org/10.2146/ajhp170039
  3. Poudel, A., Nissen, L. M., & others. (2016). Telepharmacy: A pharmacist’s perspective on the clinical benefits and challenges. Integrated Pharmacy Research and Practice, 5, 75-82.
    DOI:https://doi.org/10.2147/IPRP.S101685
  4. International Popular Scientist Awards. (n.d.). Official award and recognition platform.
    https://popularscientist.com/
  5. World Health Organization. (2021). Global strategy on digital health 2020–2025. WHO Publications.
    https://www.who.int/publications/i/item/9789240020924